Canaccord Genuity LLC

ChapmanAlbin is investigating Canaccord Genuity LLC (CRD 1020) after FINRA and federal regulators described long-running supervision and anti-money laundering failures tied to high-volume trading in low-priced over-the-counter (OTC) securities, a market often associated with microcap and penny stock risk. Public records describe gaps in surveillance and suspicious activity reporting, and also describe issues involving best execution and market integrity controls. If you traded low-priced OTC securities through this firm and experienced sharp losses, the sections below explain why these issues matter, what to review, and what documents to gather if you are evaluating next steps.

Firm Snapshot

• Firm: Canaccord Genuity LLC
• CRD: 1020
• SEC#: 8-3271
• Main office: One Pennsylvania Plaza, Suite 2900, New York, NY 10119
• Disclosure summary: Regulatory events 45; bond disclosures 1; plus 1 disclosure from a non-registered control affiliate
• Primary focus of this investigation: Regulatory findings describing trade surveillance, best execution, and AML controls tied to low-priced OTC trading activity
• Products/markets referenced in public records: Low-priced OTC securities (microcap and penny stock risk)

Further Details

FINRA information and key findings

FINRA’s AWC describes multiple issues tied to supervision, best execution, and AML controls. It states the firm did not establish and implement policies and procedures reasonably expected to detect and cause the reporting of suspicious transactions, and it describes major gaps in how surveillance was designed and used.

Regulatory and enforcement actions

Public records include a FINRA AWC with significant sanctions and undertakings, plus federal actions focused on anti-money laundering obligations and suspicious activity reporting related to OTC trading activity.

Why low-priced OTC trading, surveillance, and AML controls matter to investors

Low-priced OTC securities, including many microcap and penny stocks, can be thinly traded and volatile. These features can make manipulation easier and losses harder to avoid or unwind. In that environment, surveillance and AML monitoring matter because they are the systems designed to detect unusual trading patterns, suspicious customer activity, and potential indicators of fraud. For investors, the practical question is whether the trading in your account involved low-priced OTC securities, whether the activity raised obvious red flags, and whether you were properly informed of the risks before investing.

What investors can do and how ChapmanAlbin can help

If you traded low-priced OTC securities through Canaccord Genuity LLC and experienced losses you believe may be tied to suspicious trading, manipulation, or inadequate supervision, preserve your records and consider speaking with counsel. Depending on the facts, investor claims can involve supervision failures, misrepresentation or omission issues, and other legal theories tied to how the investments were recommended, executed, and disclosed.

Common Warning Signs

• You were steered into microcap or penny stocks without a clear explanation of liquidity and volatility risk
• Sudden price spikes or drops that appeared disconnected from fundamentals or credible news
• Heavy promotional messaging around a low-priced stock
• Difficulty selling positions or unusually wide bid-ask spreads
• Trades that did not align with your stated objectives or risk tolerance
• A pattern of losses tied to OTC names that were difficult to research

Documents to Gather

• Account statements and trade confirmations for the relevant period
• Order tickets, timestamps, and execution details (if available)
• Any written recommendations, research notes, pitch decks, or emails tied to the securities
• Any promotional materials you received or were directed to
• Notes from calls or meetings and any texts with representatives
• Records of deposits, withdrawals, and transfers connected to the trading

FAQs

What are low-priced OTC securities and why are they risky?

Low-priced OTC securities can be thinly traded and volatile, and it may be difficult to find reliable information about the issuer. These features can increase the risk of manipulation and make losses harder to recover.

What does it mean when regulators talk about suspicious activity reporting (SARs)?

SARs are reports that financial institutions file to alert authorities to suspicious transactions that could involve fraud or other illegal activity. Regulators may take enforcement action when they believe a firm’s controls were not designed or implemented in a way that reasonably detects and reports suspicious activity.

Does a regulatory settlement prove investor harm in my account?

Not necessarily. Each investor’s situation depends on what was traded, how it was recommended, what disclosures were provided, and what happened in the account.

What should I do if I suspect manipulation or misleading promotion?

Preserve your statements, confirmations, and any promotional materials. Document what you were told and when you noticed unusual trading or pricing. Then consider speaking with counsel about next steps.

Disclaimer

This page is for informational purposes only and is not legal advice. Past outcomes are not a guarantee of future results. Each matter is different and depends on its specific facts.